Physiological active materials linked biotin moiety and composition for oral administration comprising the same
WO2020242268A1
Physiologically active substance bound to biotin moiety, and composition for oral administration including same
KR102193211B1
biotin derivative-conjugated polypeptide and pharmaceutical composition for oral administration comprising the same
AU2019308089A1
Pharmaceutical composition comprising polypeptide
KR20200135618A
Pharmaceutical composition for preventing or treating nonalcoholic fatty liver disease comprising a polypeptide
KR20200010017A
Pharmaceutical composition for preventing or treating diabetes comprising a polypeptide
KR101990075B1
Pharmaceutical composition for preventing or treating obesity comprising a polypeptide
AU2015250039A1
TRAIL receptor agonists for treatment of fibrotic diseases
AU2012276478A1
Exendin-4 analogue pegylated with polyethylene glycol or derivative thereof, preparation method thereof, and pharmaceutical composition for preventing or treating diabetes, containing same as active ingredient
